Security key
03152W109
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)
CUSIP: 03152W109
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 309,836,000
- Total 13F value
- $3,309,105,094
- Share change
- -7,295,414
- Put/Call ratio
- 161%
- SEC-reported price per share
- $10.68
- Number of holders
- 289
- Value change
- -$75,379,629
- Number of buys
- 142
- Number of sells
- 117
- Shares outstanding
- 316,644,581
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
289
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
289
Shares
309,836,000
Rows available
289
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
256
Q3 2024 holders
289
Holder diff
33
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|